GlassScriptPhysician profile
Sean M Conroy
NPI 1134103534
$2,345.83
in general payments reported to CMS, 2019-2025
22 companies · $72.17 in 2025
The $72.17 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $236 · 2021: $642 · 2022: $187 · 2023: $634 · 2024: $298 · 2025: $72.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $387.67 | 2019-2024 | Senza |
| Abbvie INC. | $348.26 | 2023-2025 | Ubrelvy, Qulipta |
| Medtronic, INC. | $274.14 | 2021-2024 | Accurian, Intellis Adaptivestim, Inceptiv |
| Collegium Pharmaceutical, INC. | $260.52 | 2021-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $159.16 | 2022-2023 | Perclose Prostyle |
| Scilex Pharmaceuticals INC. | $150.03 | 2020-2023 | Ztlido |
| Virtus Pharmaceuticals LLC | $95.38 | 2020-2021 | |
| Amgen INC. | $84.51 | 2020-2021 | |
| Vertiflex, INC. | $82.25 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $74.10 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $74.06 | 2020-2021 | |
| Boston Scientific Corporation | $68.94 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $52.30 | 2022 | |
| Pfizer INC. | $47.80 | 2023-2024 | |
| Saluda Medical Americas, INC. | $38.07 | 2023 | Evoke Scs |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $35.20 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.73 | 2021 | |
| Redhill Biopharma INC. | $24.40 | 2020 | |
| Stimwave Technologies Incorporated | $16.51 | 2022 | |
| Nalu Medical, INC. | $14.81 | 2022 | |
| Horizon Therapeutics Plc | $14.03 | 2020 | |
| Bioventus LLC | $13.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Conroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.